The Current Ratio as of December 2024 (TTM) for Vascular Biogenics Ltd. (VBLT) is 2.77

According to Vascular Biogenics Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 2.77. This represents a change of -28.60% compared to the average of 3.89 of the last 4 quarters.

Vascular Biogenics Ltd. (VBLT) Historical Current Ratio (quarterly & annually)

How has VBLT Current Ratio performed in the past?

The mean historical Current Ratio of Vascular Biogenics Ltd. over the last ten years is 6.17. The current 2.77 Current Ratio has changed 4.40% with respect to the historical average. Over the past ten years (40 quarters), VBLT's Current Ratio was at its highest in in the September 2021 quarter at 6.75. The Current Ratio was at its lowest in in the June 2024 quarter at 2.77.

Vascular Biogenics Ltd. (VBLT) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Vascular Biogenics Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Vascular Biogenics Ltd. (VBLT) Average Current Ratio

How has VBLT Current Ratio performed in the past?

The current Current Ratio of Vascular Biogenics Ltd. (VBLT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Vascular Biogenics Ltd. (VBLT) Current Ratio vs. Peers

How is VBLT’s Current Ratio compared to its peers?

Vascular Biogenics Ltd.’s Current Ratio is greater than Revelation Biosciences, Inc. (1.64), less than Zura Bio Limited (10.36), less than Phio Pharmaceuticals Corp. (6.38), less than ZyVersa Therapeutics, Inc. (33.83), greater than TransCode Therapeutics, Inc. (1.58), less than Panbela Therapeutics, Inc. (0), greater than Virax Biolabs Group Limited (0.26), less than Allarity Therapeutics, Inc. (25.94), greater than ContraFect Corporation (2.75), greater than Avenue Therapeutics, Inc. (0.53), greater than Acumen Pharmaceuticals, Inc. (2.70), less than HOOKIPA Pharma Inc. (10.43), less than Day One Biopharmaceuticals, Inc. (3.26), less than Inozyme Pharma, Inc. (14.62), less than Terns Pharmaceuticals, Inc. (7.68), less than X4 Pharmaceuticals, Inc. (32.99), less than Galera Therapeutics, Inc. (4.89), less than null (9.74),

Build a custom stock screener for Vascular Biogenics Ltd. (VBLT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vascular Biogenics Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vascular Biogenics Ltd. (VBLT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vascular Biogenics Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.